Canada markets closed

Artemis Therapeutics Inc. (ATMS)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.11250.0000 (0.00%)
At close: 03:56PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 124.64M
Enterprise Value 124.91M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)85.79
Price/Book (mrq)N/A
Enterprise Value/Revenue 664.41
Enterprise Value/EBITDA -140.66

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-66.97%
S&P500 52-Week Change 3-11.63%
52 Week High 35.0000
52 Week Low 30.7500
50-Day Moving Average 31.2853
200-Day Moving Average 32.1043

Share Statistics

Avg Vol (3 month) 3177
Avg Vol (10 day) 3140
Shares Outstanding 5112.03M
Implied Shares Outstanding 6N/A
Float 814.48M
% Held by Insiders 187.78%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 19, 2016
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3Dec 19, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-525.14%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)195.06k
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)3,833.30%
Gross Profit (ttm)6.26k
EBITDA -1.01M
Net Income Avi to Common (ttm)-1.03M
Diluted EPS (ttm)-0.0260
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)85k
Total Cash Per Share (mrq)0
Total Debt (mrq)356k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.31
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-465.86k
Levered Free Cash Flow (ttm)N/A